Substance / Medication

Pramlintide acetate

Overview

Clinical overview including description, indications, and evidence base is pending physician authorship or FDA SPL integration. Graph-derived relationship data is available below.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

Clinical Trials

903 trials linked to this intervention

903
Total Trials
103
Recruiting
282
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Model-Based Meta-Analysis of the Relationship Between Pioglitazone and Histological Outcomes in Metabolic Dysfunction-Associated Steatohepatitis Patients.
Tran Quyen Thi, Bui Tham Thi, Ngo Lien Thi et al. · CPT Pharmacometrics Syst Pharmacol · 2026
PMID: 40248984Meta-AnalysisFull text (PMC)
Prevalence of congenital anomalies in pregnancies complicated by type 2 diabetes: Systematic review and meta-analysis.
Oppermann Maria Lúcia R, Campos Maria Amélia A, Guerra Giulia L et al. · Int J Gynaecol Obstet · 2026
PMID: 40682407Meta-Analysis
Intensive Blood Pressure Control in Type 2 Diabetes: A Systematic Review and Meta-Analysis of Cardiovascular and Microvascular Outcomes.
Mousavi Asma, Shojaei Shayan, Abhari Amir Parsa et al. · Am J Hypertens · 2026
PMID: 40717314Meta-Analysis
Pramlintide acetate injection for the treatment of type 1 and type 2 diabetes mellitus.
Singh-Franco Devada, Robles Gisela, Gazze David · Clin Ther · 2007
PMID: 17617279Review
Pramlintide acetate.
McQueen Joanna · Am J Health Syst Pharm · 2005
PMID: 16278328Review
Study of forced degradation behavior of pramlintide acetate by HPLC and LC-MS.
Yuan Yu, Li Yuan-Bo, Tai Zheng-Fu et al. · J Food Drug Anal · 2018
PMID: 29389581OtherFull text (PMC)
Pramlintide acetate in the treatment of Type 2 and Type 1 diabetes mellitus.
Edelman Steven V, Schroeder Brock E, Frias Juan P · Expert Rev Endocrinol Metab · 2007
PMID: 30743744Other

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Health Goals

Goals connected through associated conditions

Quick Facts

Type
Substance / Medication
Fully Specified Name
Pramlintide acetate (substance)
SNOMED CT
427360000
UMLS CUI
C1174779

Clinical Data

This intervention maps to 11 entities in the Ltrl knowledge graph.

2
Conditions
4
Biomarkers
3
Specialists
0
Symptoms
903
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.